Novel Triazolopyridine-Based BRD4 Inhibitors as Potent HIV-1 Latency Reversing Agents.
Wang YK, Huang XS, Sun H, Ma MD, Yu HP, Hu W, Li ZY, Li Z, Luo RH, Tian RR, Xiao TF, Yang LM, Zheng YT, Li X.
Wang YK, et al.
ACS Med Chem Lett. 2023 Dec 14;15(1):60-68. doi: 10.1021/acsmedchemlett.3c00373. eCollection 2024 Jan 11.
ACS Med Chem Lett. 2023.
PMID: 38229757
Free PMC article.